Figures & data
Table 1. Demographics of the study parameters, with population divided into three subgroups based upon IIEF-5 SHIM Scores for severity of ED.
Figure 1. Weight and waist circumference (mean ± SD) stratified by subgroups of men with varying severity of ED [SHIM 1–7, severe ED (S), 8–11 moderate ED (M) and 12–16 mild to moderate (MM)]. *One-way ANOVA sig. p < 0.05.
![Figure 1. Weight and waist circumference (mean ± SD) stratified by subgroups of men with varying severity of ED [SHIM 1–7, severe ED (S), 8–11 moderate ED (M) and 12–16 mild to moderate (MM)]. *One-way ANOVA sig. p < 0.05.](/cms/asset/c6f5f44d-a10e-4e11-935c-91f503e6a800/itam_a_1046044_f0001_b.jpg)
Figure 2. Total cholesterol and triglyceride levels (mean ± SD) between subgroups of men with varying severity of ED [SHIM 1–7, severe ED (S), 8–11 moderate ED (M) and 12–16 mild to moderate (MM)]. *One-way ANOVA sig. p < 0.05.
![Figure 2. Total cholesterol and triglyceride levels (mean ± SD) between subgroups of men with varying severity of ED [SHIM 1–7, severe ED (S), 8–11 moderate ED (M) and 12–16 mild to moderate (MM)]. *One-way ANOVA sig. p < 0.05.](/cms/asset/ef3ca7a9-a297-46c9-bb44-2fa49ab30549/itam_a_1046044_f0002_b.jpg)
Figure 3. Glycosylated haemoglobin (HbA1c) levels (mean ± SD) between subgroups of men with varying severity of ED [SHIM 1–7, severe ED (S), 8–11 moderate ED (M) and 12–16 mild to moderate (MM)]. *One-way ANOVA sig. p < 0.05.
![Figure 3. Glycosylated haemoglobin (HbA1c) levels (mean ± SD) between subgroups of men with varying severity of ED [SHIM 1–7, severe ED (S), 8–11 moderate ED (M) and 12–16 mild to moderate (MM)]. *One-way ANOVA sig. p < 0.05.](/cms/asset/5a2935db-805f-4ffe-a015-ea0ca1e4715e/itam_a_1046044_f0003_b.jpg)
Figure 4. Serum fasting glucose levels (mean ± SD) between subgroups of men with varying severity of ED [(SHIM 1-7, severe ED (S), 8-11 moderate ED (M), and 12-16 mild to moderate (MM)]. *One way ANOVA Sig. p < 0.05.
![Figure 4. Serum fasting glucose levels (mean ± SD) between subgroups of men with varying severity of ED [(SHIM 1-7, severe ED (S), 8-11 moderate ED (M), and 12-16 mild to moderate (MM)]. *One way ANOVA Sig. p < 0.05.](/cms/asset/a053c168-8535-45e6-8880-ee8db1ff1396/itam_a_1046044_f0004_b.jpg)
Figure 5. Total AMS Scores (mean ± SD) between subgroups of men with varying severity of ED [SHIM 1–7, severe ED (S), 8–11 moderate ED (M) and 12–16 mild to moderate (MM)]. *One-way ANOVA sig. p < 0.05.
![Figure 5. Total AMS Scores (mean ± SD) between subgroups of men with varying severity of ED [SHIM 1–7, severe ED (S), 8–11 moderate ED (M) and 12–16 mild to moderate (MM)]. *One-way ANOVA sig. p < 0.05.](/cms/asset/d44f7966-a7ca-494f-81f4-f118235433e1/itam_a_1046044_f0005_b.jpg)
Figure 6. Percentage of patients with type 2 diabetes mellitus (T2D) amongst subgroups of men with varying severity of ED [SHIM 1–7, severe ED (S), 8–11 moderate ED (M) and 12–16 mild to moderate (MM)]. *Pearson chi-square test (χ2) sig. p < 0.05.
![Figure 6. Percentage of patients with type 2 diabetes mellitus (T2D) amongst subgroups of men with varying severity of ED [SHIM 1–7, severe ED (S), 8–11 moderate ED (M) and 12–16 mild to moderate (MM)]. *Pearson chi-square test (χ2) sig. p < 0.05.](/cms/asset/422c1821-8085-4e6f-bfc3-7e3f88f0aa92/itam_a_1046044_f0006_b.jpg)